MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
MetLife, Inc.NYSE: MET
Total Assets · Q2 FY2026 · quarter ended Jun 2026
Total assets rises 8.1% from a year ago
Total assets stood at $759.37B at the end of Q2 FY2026, up 8.1% from a year earlier and up 2.2% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.
Context
- Total assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +8.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 745.17B USD
- Year-over-year change
- +10.0%
- 4-year CAGR
- -0.5%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 745.17B | +10.0% |
| FY2024 | 2024-12-31 | 677.46B | -1.5% |
| FY2023 | 2023-12-31 | 687.58B | +3.7% |
| FY2022 | 2022-12-31 | 663.07B | -12.7% |
| FY2021 | 2021-12-31 | 759.71B | — |
Total Assets vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
- Its year-over-year change of +8.1% is the 2nd highest of 11, against a peer median of +4.6%.
- Over three fiscal years its annual growth of +4.0% compares with a peer median of +4.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jun 2026 | CA$1.09T CAD | +11.9% | +7.1% | |
| Jun 2026 | $783.55B USD | +3.2% | +3.9% | |
| Jun 2026 | $759.37B USD | +8.1% | +4.0% | |
| Jun 2026 | $429.8B USD | +7.7% | +7.7% | |
| Sep 2026 | $238.66B USD | -2.1% | +2.5% | |
| Jun 2026 | $182.95B USD | +6.1% | +6.9% | |
| Jun 2026 | $115.96B USD | -7.0% | -4.0% | |
| Jun 2026 | $63.49B USD | +1.0% | +1.4% | |
| Jun 2026 | $39.8B USD | +6.6% | +5.4% | |
| Jun 2026 | $31.56B USD | +5.9% | +5.8% | |
| Sep 2026 | $14.48B USD | -2.5% | +0.8% | |
| Peer median (excluding MET) | — | +4.6% | +4.6% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 20.05B | 20.2B | 20.64B | 20.07B | 22.03B |
| Short-term Investments | 347.45B | 293.13B | 296.19B | 88.71B | 103.31B |
| Net Receivables | 20.52B | 22.17B | 33.78B | 34.26B | 54.25B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 388.02B | 335.49B | 350.62B | 143.04B | 179.59B |
| Property, Plant & Equipment (Net) | 0 | 1.93B | 1.99B | 1.85B | 1.7B |
| Goodwill | 9.54B | 9.3B | 9.24B | 8.9B | 9.61B |
| Intangible Assets | 16.06B | 19.65B | 20.15B | 19.63B | 21.11B |
| Long-term Investments | 147.37B | 134.83B | 144.19B | 346.67B | 362.81B |
| Tax Assets | 189M | 2.44B | 2.61B | 2.99B | 2.59B |
| Other Non-current Assets | 198.54B | 159.44B | 158.79B | 154.38B | 167.77B |
| Total Non-current Assets | 371.69B | 327.58B | 336.97B | 534.42B | 565.58B |
| Total Assets | 759.71B | 663.07B | 687.58B | 677.46B | 745.17B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 341M | 175M | 119M | 465M | 1.56B |
| Tax Payables | 0 | 42M | 190M | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 230.92B | 229.97B | 239.93B | 240.48B | 257.46B |
| Total Current Liabilities | 263.18B | 251.08B | 257.58B | 258.07B | 276.14B |
| Long-term Debt | 17.09B | 17.75B | 18.68B | 18.24B | 18.62B |
| Deferred Tax Liabilities | 9.69B | 950M | 927M | 132M | 536M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 402B | 363.11B | 380.12B | 373.3B | 420.95B |
| Total Non-current Liabilities | 428.78B | 381.86B | 399.76B | 391.69B | 440.11B |
| Total Liabilities | 691.96B | 632.95B | 657.33B | 649.75B | 716.25B |
| Common Stock | 12M | 12M | 12M | 12M | 12M |
| Retained Earnings | 41.2B | 40.33B | 40.15B | 42.63B | 44.29B |
| Accumulated OCI | 10.92B | (22.62B) | (19.24B) | (21.19B) | (18.08B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 267M | 244M | 238M | 258M | 523M |
| Total Equity | 67.75B | 30.13B | 30.25B | 27.7B | 28.92B |
| Total Debt | 17.43B | 17.98B | 18.83B | 18.72B | 20.18B |
| Net Debt | (2.62B) | (2.22B) | (1.81B) | (1.35B) | (1.85B) |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.